Global Autogenous Vaccines Market Report and Forecast 2024-2032

Global Autogenous Vaccines Market Outlook

The global autogenous vaccines market size was valued at USD 136.65 million in 2023, driven by the rising prevalence of contagious diseases across the globe as it is generating demand for customised autogenous vaccines. The market is anticipated to grow at a CAGR of 5.6% during the forecast period 2024-2032 to reach a value of USD 223.14 million by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Provision of Funds by Several Governments is Aiding the Growth of Autogenous Vaccines Industry

The market for autogenous vaccines is driven by the rising provision of funds by several governments and international communities of public and private benefactors for the control and eradication programmes. For example, European Animal Health Strategy Programs have contributed significantly to the industry. The rising focus of government organisations towards the immunisation of animals is expected to propel the market growth over the forecast period. Further, the international agencies and organisations like Center for Disease Prevention and Control, Food and Agriculture Organization, and World Organization for Animal Health (OIE) have significantly contributed to the reduction of animal diseases and regulating and controlling programmes for animal diseases. Besides, the market is influenced by the growing focus on innovations for the prevention and treatment of zoonotic diseases.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Autogenous Vaccines: Market Segmentation

An autogenous vaccine is refers to a vaccine that is developed from cultures of microorganisms accumulated from individuals and then used to immunise the same individual against further propagation and development of the same microorganisms.

On the basis of strain type, the market is divided into:

• Bacterial Strain
• Virus Strain

Based on end use, the industry can be segmented into:

• Veterinary Clinics
• Veterinary Hospitals
• Veterinary Research Institutes
• Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Prevalence of Contagious Diseases to Aid the Market Growth of Autogenous Vaccines Industry

The market for autogenous vaccines is driven by the rising prevalence of contagious diseases across the globe as it is generating demand for customised autogenous vaccines. Animals are susceptible to a wide range of contagious diseases like pink eyes and peste des petits ruminants (PPR) / goat plague, a highly contagious disease that generally affects ruminants. As reported by the Food and Agricultural Organization, peste des petits ruminants (PPR) virus or goat plague can contaminate approximately 90% of small ruminant inhabitants. The outbreak of contagious diseases severely interrupts livestock production, leading to direct and indirect financial losses. The government organisations as well as public organisations contribute the economic resources for the prevention and control of contagious infection in livestock, which is expected to facilitate the market growth of autogenous vaccines during the forecast period.

Key Industry Players in the Global Autogenous Vaccines Market

The report gives a detailed analysis of the following key players in the global autogenous vaccines market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Newport Laboratories, Inc.
• Elanco Animal Health Inc.
• Cambridge Technologies
• Hygieia Biological Laboratories
• AniCon Labor GmbH
• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report